GNH USA

Europe — EMA

Jablerdiz (Cytisinicline)

GNH USA supplies Jablerdiz (Cytisinicline), a nicotinic acetylcholine receptor partial agonist for smoking cessation. Request a quote for global supply.

Cytisinicline

Request sourcing

1
Pack/s

What is Cytisinicline?

Cytisinicline, the active ingredient in Jablerdiz, is a nicotinic acetylcholine receptor partial agonist presented as a tablet for oral use. It is used to aid smoking cessation in adults who are motivated to quit nicotine use.

GNH USA supplies Jablerdiz as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

What is Cytisinicline used for?

Jablerdiz is a nicotinic receptor partial agonist indicated for smoking cessation. It helps reduce nicotine cravings and withdrawal symptoms in individuals attempting to quit smoking.

- Smoking cessation: reduces cravings and withdrawal symptoms, supporting abstinence from tobacco. - Nicotine dependence: assists adults in managing dependence on nicotine during quit attempts. - Relapse prevention: helps maintain abstinence by moderating nicotine‑related urges.

What are the side effects of Cytisinicline?

Cytisinicline may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headache. - Insomnia: difficulty falling or staying asleep. - Vivid dreams: unusually intense or memorable dreams. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Mood changes: depression or anxiety worsening. - Seizures: rare convulsive episodes. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Cardiovascular events: hypertension or arrhythmia. - Psychiatric symptoms: hallucinations or psychosis. - Liver enzyme elevation: abnormal liver function tests.

What precautions apply to Cytisinicline?

Before prescribing Jablerdiz, clinicians should consider several safety aspects.

- Cardiovascular assessment: evaluate blood pressure and heart disease history. - Neuropsychiatric monitoring: watch for mood or anxiety changes. - Hypertension caution: avoid use in uncontrolled high blood pressure. - Withdrawal counseling: advise patients about possible nicotine withdrawal symptoms. - Concomitant medication review: check for interactions with other CNS agents. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Cytisinicline interact with?

Cytisinicline can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis. - Strong CYP2A6 inhibitors: may increase Cytisinicline plasma levels.

Moderate Interactions (Monitor Closely): - Nicotine replacement therapy: additive nicotine effects may increase side‑effects. - Antidepressants (SSRIs, SNRIs): potential for serotonin syndrome. - Antihypertensives: possible reduction in blood pressure control. - Antiepileptic drugs: may alter seizure threshold.

Frequently asked questions

What is Jablerdiz used for?+
Jablerdiz contains Cytisinicline and is used as a prescription medication to help adults quit smoking. It works by reducing nicotine cravings and easing withdrawal symptoms, supporting individuals who are motivated to stop using tobacco products.
How does Cytisinicline work in the body?+
Cytisinicline is a partial agonist at the α4β2 nicotinic acetylcholine receptors in the brain. By partially stimulating these receptors, it provides enough activation to lessen nicotine cravings while preventing the full stimulant effect of nicotine, thereby helping to manage dependence.
What is the usual dose of Jablerdiz?+
The specific dose and dosing schedule of Jablerdiz are determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the prescriber’s instructions exactly.
Is Jablerdiz safe to use during pregnancy or breastfeeding?+
Safety data for Cytisinicline in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Jablerdiz to pregnant or breastfeeding individuals, and alternative treatments may be considered.
How do I order Jablerdiz from GNH USA?+
To request Jablerdiz, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Jablerdiz compare with other smoking‑cessation drugs?+
Jablerdiz (Cytisinicline) belongs to the class of nicotinic receptor partial agonists, similar to varenicline but with a distinct binding profile. It may offer comparable efficacy in reducing cravings while presenting a different side‑effect spectrum, which can influence the choice of therapy based on patient tolerance and physician preference.
What are the storage requirements for Jablerdiz?+
Jablerdiz should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.
How is Jablerdiz administered?+
Jablerdiz is taken orally, typically as a tablet, with or without food as directed by the prescriber. The exact administration schedule, including timing and duration, should follow the healthcare professional’s guidance.
What are the most serious risks associated with Jablerdiz?+
Serious risks include mood alterations such as depression or anxiety, rare seizures, severe allergic reactions, and cardiovascular events like hypertension. Patients should seek immediate medical attention if they experience any of these symptoms.
Who should not use Jablerdiz?+
Jablerdiz is contraindicated in individuals with known hypersensitivity to Cytisinicline or any tablet excipients, and it should be used with caution in patients with uncontrolled hypertension, severe psychiatric disorders, or a history of seizures. The prescriber will assess suitability on a case‑by‑case basis.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Cytisinicline
Route
Oral Use
Manufacturer
Adamed Pharma S.A.
Origin
EU

Related products

Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Asmoken

Asmoken

Cytisinicline

Aflofarm Farmacja Polska Sp. Z O.O.
EU
Belnifrem

Belnifrem

Cytisinicline

Adamed Pharma S.A.
EU